Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
- 1 May 1995
- Vol. 73 (5) , 486-487
- https://doi.org/10.1136/hrt.73.5.486
Abstract
Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).Keywords
This publication has 6 references indexed in Scilit:
- Prolonged survival in patients with beta-thalassemia major treated with deferoxamineThe Journal of Pediatrics, 1991
- Cardiopulmonary Assessment in Beta-Thalassemia MajorChest, 1990
- Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major.Circulation, 1990
- High Incidence of Cardiomyopathy in Beta-Thalassaemia Patients Receiving Regular Transfusion and Iron Chelation: Reversal by Intensified ChelationActa Haematologica, 1990
- Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overloadJournal of the American College of Cardiology, 1986
- [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].1985